MedTrace Logo

Pilot Cohort Study of Rb-82 Myocardial PET Imaging to Evaluate Coronary Microvascular Dysfunction in Men With Prostate Cancer Receiving Androgen-Deprivation Therapy

NCT03535987 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2024-11-19

No results posted yet for this study

Summary

To determine the feasibility of using myocardial PET imaging as a means to assess cardiovascular risk in men with prostate cancer planned for androgen- deprivation therapy with external beam radiation therapy.

Conditions

Interventions

DEVICE

myocardial PET imaging

using myocardial PET imaging as a means to assess cardiovascular risk in men with prostate cancer planned for androgen-deprivation therapy with external beam radiation therapy

Sponsors & Collaborators

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Vivek Narayan, MD · Abramson Cancer Center at Penn Medicine

Eligibility

Min Age
51 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-19
Primary Completion
2019-04-19
Completion
2019-10-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03535987 on ClinicalTrials.gov